Faculty & Research Interests


Rebecca Cope, Pharm.D., BCACP
Assistant Professor, Pharmacy Practice
(718) 246-6332


Pharm.D., Albany College of Pharmacy and Health Sciences

Short Biography

Dr. Rebecca Cope, PharmD, BCACP earned her PharmD from Albany College of Pharmacy and Health Sciences in 2013. She served as the Chief Pharmacy Resident during her PGY-1 residency training at The Brooklyn Hospital in Brooklyn, NY before going on to complete a PGY-2 residency in global health and underserved care through the University of Pittsburgh/UPMC in Pittsburgh, PA. She obtained board certification in ambulatory care in 2016 and accepted her current position at LIU College of Pharmacy in 2017. Her practice expertise includes primary care in limited resource settings, and she maintains a clinical practice in the Anticoagulation Clinic, Family Medicine Clinic and HIV Primary Care Center at The Brooklyn Hospital. Dr. Cope additionally serves as a preceptor for the PGY-2 ambulatory care pharmacy residency at her institution and is heavily involved with research in both the pharmacy and medical residency programs. Her research focus has been on exploring health disparities, Hepatitis C and HIV/AIDS, and the pharmacist’s role in the interdisciplinary team. Dr. Cope has spent a significant amount of time doing medical work in Honduras and Malawi throughout her career and has a strong interest in global health.

Research Synopsis

Primary Care/Family Medicine/Global

Health: Pharmacist’s role in chronic disease state management, including diabetes, lipids, hypertension, and others; Chronic disease state management in patients living with HIV/AIDS; Safe and efficacious use of anticoagulant therapy; Qualitative research on patient perceptions and understanding of health risk associated with chronic disease states; Capacity building for chronic disease state management in global health settings; Impact of incorporating global health education into pharmacy curriculums.

Selected Publications

  • Cope R, Jonkman L, Quach K, Ahlborg J, Connor S. “Transitions of Care: Medication related barriers identified by low socioeconomic patients of a federally qualified health center following hospital discharge.” RSAP. 2017 Jan 6 [ePub ahead of print].
  • Greenwald R, Cope R, Mangurian C. “Chipping Away at Medicaid Restrictions to Direct-Acting Antiviral Coverage / Interview by Rob Volansky [Transcript]. HCV Next. May 2016.
  • Sorbera M, Friedman M, Cope R. “New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment.” J Pharm Pract. 2016 Feb 22.
  • Cope R, Glowa T, Faulds S, McMahon D, Prasad R. “Treating Hepatitis C in a Ryan-White Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era?” AIDS Patient Care STDS. 2016 Feb;30(2):51-5.
  • Cope R, Berkowitz L, Arcebido R, Trustman N, Yeh J, Cha A. “Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist Collaboration on HIV Patient Co-Morbidities.” AIDS Patient Care and STDS. 2015 Aug;29(8):445-53.
  • Cope R, Pickering A, Glowa T, Faulds S, Veldkamp P, Prasad R. “Majority of HIV/HCV Patients Need to Switch ART to Accommodate Simeprevir.” AIDS Patient Care and STDs. 2015 Jul;29(7): 379-83


LIU Pharmacy
Arash T. Dabestani